Inhibition of sulphate incorporation by chondrocytes in intact cartilage by hyaluronate from foetal cartilage.
A number of regulators are available in cartilage to effect the local control of matrix production by chondrocytes. A cartilage slice assay has been used in this study to investigate the influence of such regulators (extracted from foetal cartilage) on intact cartilage. A net inhibition of sulphation was found, rather than stimulation as reported for extracts rich in the somatomedin-like, cartilage derived factor (CDF). Inhibition was due, to a high molecular weight component identified as hyaluronic acid (based on enzyme sensitivity, chromatographic behaviour and temperature stability). Its inhibition of sulphation in intact cartilage was more profound than that produced by commercially available umbilical cord hyaluronate. We conclude that foetal cartilage hyaluronate is a far more potent inhibitor of sulphation than hyaluronate from other sources, suppressing sulphation even in the presence of a somatomedin-like activator and in intact cartilage, which responds poorly to commercial hyaluronate.
Brown
R A
RA
Institute of Orthopaedics, University of London and Middlesex School of Medicine.
Taylor
A M
AM
McDowell
J M
JM
D000818:Animals; D002356:Cartilage / Q000032:analysis / Q000196:embryology* / Q000378:metabolism; D002417:Cattle; D002848:Chromatography, DEAE-Cellulose; D002850:Chromatography, Gel; D006801:Humans; D006820:Hyaluronic Acid / Q000302:isolation & purification / Q000494:pharmacology*; D006863:Hydrogen-Ion Concentration; D007334:Insulin-Like Growth Factor I / Q000494:pharmacology; D008970:Molecular Weight; D013431:Sulfates / Q000378:metabolism*
D013431:Sulfates; D007334:Insulin-Like Growth Factor I; D006820:Hyaluronic Acid